OTC Markets OTCQX - Delayed Quote USD
Roche Holding AG (RHHBY)
39.79
+0.68
+(1.74%)
As of 2:35:01 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | 0 | 0 | 2.97 | 3.13 |
| Low Estimate | 0 | 0 | 2.9 | 3.05 |
| High Estimate | 0 | 0 | 3.05 | 3.19 |
| Year Ago EPS | -- | -- | 2.59 | 2.97 |
Revenue Estimate
| Currency in CHF | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 18 | 18 |
| Avg. Estimate | 15.34B | 15.95B | 64.55B | 67.32B |
| Low Estimate | 15.23B | 15.95B | 62.67B | 64.69B |
| High Estimate | 15.44B | 15.95B | 66.44B | 70.34B |
| Year Ago Sales | 14.4B | 15.45B | 60.49B | 64.55B |
| Sales Growth (year/est) | 6.54% | 3.24% | 6.71% | 4.29% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 2.97 | 3.13 |
| 7 Days Ago | 0 | 0 | 2.94 | 3.11 |
| 30 Days Ago | 0 | 0 | 2.93 | 3.07 |
| 60 Days Ago | 0 | 0 | 2.95 | 0 |
| 90 Days Ago | 0 | 0 | 3.01 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RHHBY | -- | -- | 14.69% | 5.47% |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Maintains | TD Cowen: Market Perform to Market Perform | 9/12/2023 |
| Downgrade | Cowen & Co.: Outperform to Market Perform | 11/15/2022 |
| Maintains | Cowen & Co.: Outperform | 6/27/2022 |
| Upgrade | Deutsche Bank: Hold to Buy | 7/8/2021 |
| Initiated | Argus Research: Buy | 1/28/2019 |
| Upgrade | Credit Suisse: Underperform to Neutral | 1/28/2019 |
Related Tickers
SNY Sanofi
53.57
+1.04%
NVS Novartis AG
111.09
+0.87%
GSK GSK plc
37.35
+0.85%
AZN AstraZeneca PLC
69.42
+1.33%
AMGN Amgen Inc.
279.14
+0.45%
BMY Bristol-Myers Squibb Company
48.55
+0.03%
BIIB Biogen Inc.
119.90
+1.46%
MRK Merck & Co., Inc.
79.53
+1.00%
GILD Gilead Sciences, Inc.
106.37
-0.01%
BAYRY Bayer Aktiengesellschaft
6.42
+2.39%